General Atlantic Leads $300M Series D Growth Round in Biofourmis

CopilotIQ and Biofourmis Merge to Create AI-Driven In-Home Care Platform

October 21, 2024

Healthcare Services

CopilotIQ and Biofourmis announced a strategic merger to create a combined, end-to-end AI-driven platform for in‑home care spanning pre-surgery, acute, post-acute, and chronic care. Leading investors from both companies — including General Atlantic, Openspace Ventures, and Bessemer Venture Partners — are reinvesting in the combined business to support expansion and product integration.

Bain Capital Tech Opportunities Leads $145M Series C Investment in BioCatch

April 15, 2020

Cybersecurity

BioCatch, a leader in behavioral biometrics for fraud detection, closed a $145 million Series C round led by Bain Capital Tech Opportunities with participation from Industry Ventures, American Express Ventures, CreditEase, Maverick Ventures, OurCrowd and others. The growth capital will accelerate BioCatch’s expansion, broaden product offerings and support entry into new verticals and geographies.

General Atlantic Acquires Majority Stake in CareMetx; Vistria Reinvests

January 14, 2021

Healthcare Services

General Atlantic has entered a strategic growth partnership to become the majority owner of CareMetx, a Bethesda-based technology-enabled hub services company that supports patient access to specialty medications. Existing majority shareholder The Vistria Group is reinvesting and Marty Nesbitt (Vistria) will serve as CareMetx chairman; financial terms were not disclosed.

TPG Capital and Vida Ventures Invest $225M in Asklepios BioPharmaceutical (AskBio)

April 11, 2019

Biotechnology

Asklepios BioPharmaceutical (AskBio) raised $235 million in new capital, with TPG Capital and Vida Ventures investing $225 million for a minority stake while AskBio’s founders and board co-invested $10 million. The funding will be used to accelerate clinical development and expand manufacturing capabilities, particularly for AskBio’s AAV gene therapy platform and pipeline.

CVS Health Leads $25M Growth Round in Array Behavioral Care

June 1, 2023

Healthcare Services

Array Behavioral Care closed a $25 million equity financing round led by CVS Health, with participation from existing investors including Wells Fargo Strategic Capital, Health Velocity Capital, Harbour Point Capital, HLM Venture Partners, OCA Ventures, and OSF HealthCare. The capital will be used to scale Array’s virtual psychiatry and therapy services, enhance technology and operations, and expand access through deeper collaboration with CVS Health.

BYG4lab to Acquire Finbiosoft with Support from Keensight Capital

March 14, 2024

Software

BYG4lab has signed an exclusivity agreement to acquire Finbiosoft, a Finland-based provider of quality and laboratory software for medical laboratories, with the support of Keensight Capital. The deal is intended to broaden BYG4lab's product capabilities, add Finbiosoft's technical team, and expand the group's geographic footprint across Europe and into the United States while enabling cross-selling to an expanded client base.